INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 171 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $433,000 | +3.6% | 7,038 | -1.6% | 0.00% | 0.0% |
| Q4 2017 | $418,000 | +0.7% | 7,155 | +0.2% | 0.00% | 0.0% |
| Q3 2017 | $415,000 | -76.8% | 7,144 | -51.6% | 0.00% | -60.0% |
| Q2 2017 | $1,788,000 | +146.3% | 14,770 | +130.1% | 0.01% | +25.0% |
| Q1 2017 | $726,000 | -7.9% | 6,420 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $788,000 | -25.4% | 6,420 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $1,057,000 | +30.7% | 6,420 | +13.2% | 0.01% | +20.0% |
| Q2 2016 | $809,000 | +6.0% | 5,671 | -4.5% | 0.01% | 0.0% |
| Q1 2016 | $763,000 | +1.5% | 5,937 | +17.9% | 0.01% | 0.0% |
| Q4 2015 | $752,000 | -15.4% | 5,037 | -6.1% | 0.01% | -16.7% |
| Q3 2015 | $889,000 | -73.7% | 5,362 | -61.8% | 0.01% | -68.4% |
| Q2 2015 | $3,386,000 | -14.4% | 14,027 | 0.0% | 0.02% | -17.4% |
| Q1 2015 | $3,956,000 | +115.4% | 14,027 | +19.1% | 0.02% | +109.1% |
| Q4 2014 | $1,837,000 | +37.8% | 11,777 | +109.1% | 0.01% | +37.5% |
| Q3 2014 | $1,333,000 | -11.4% | 5,633 | -11.4% | 0.01% | 0.0% |
| Q2 2014 | $1,505,000 | – | 6,360 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
| Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
| DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
| GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
| BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
| Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
| ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
| Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
| QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
| Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |